6. Other Assets

Perpetual License

On September 15, 2008, MHS entered into an agreement with iMedica (now Aprima Medical Software, Inc., or "Aprima") (the "Aprima Agreement"), under which the Company has a perpetual license to certain software code developed by Aprima, which the Company has incorporated into its Allscripts MyWay product. The perpetual license is being amortized over its estimated useful life of seven years, and is included in other assets on the consolidated balance sheets. On July 17, 2009, the Company and Aprima entered into an amendment to the License Agreement to settle a dispute relating to certain terms of the License Agreement. As consideration for entering into this amendment, Allscripts paid Aprima $2 million, which is reflected in selling, general and administrative expenses on the consolidated statement of operations for the year ended May 31, 2010.

As part of the License Agreement, MHS agreed to pay Aprima a total of $12 million in cash contingent upon delivery by Aprima and acceptance by MHS of the licensed code and services, and to surrender its minority equity stake in Aprima along with any outstanding prepaid royalties. Misys made the $12 million payment on MHS' behalf. During the three months ended November 30, 2008, the Company reviewed the fair market value of its Aprima software code license and determined that it was impaired. The impairment was valued by comparing the expected discounted future cash flows to be generated by the Aprima source code license to its carrying value. The resulting impairment charge of $14 million was recorded in selling, general and administrative expenses during the year ended May 31, 2009.

The net value of the perpetual license was as follows:


	December 31,
(In thousands)	2011		2010
Net value of perpetual license		$5,936		$7,436

Amortization expense of the perpetual license was as follows:

Year Ended
December 31,
2011

Seven Months
Ended
December 31,
2010

Year Ended May 31,

(In thousands)

2010

2009

Amortization expense of perpetual license

$1,500

$875

$1,500

$689